Joseph McCarville

947 total citations
22 papers, 769 citations indexed

About

Joseph McCarville is a scholar working on Molecular Biology, Infectious Diseases and Hepatology. According to data from OpenAlex, Joseph McCarville has authored 22 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Infectious Diseases and 9 papers in Hepatology. Recurrent topics in Joseph McCarville's work include Hepatitis C virus research (9 papers), HIV/AIDS drug development and treatment (8 papers) and Biochemical and Molecular Research (4 papers). Joseph McCarville is often cited by papers focused on Hepatitis C virus research (9 papers), HIV/AIDS drug development and treatment (8 papers) and Biochemical and Molecular Research (4 papers). Joseph McCarville collaborates with scholars based in United States, Germany and France. Joseph McCarville's co-authors include Dale A. Ramsden, Stephanie A. Nick McElhinny, Yue Xiong, Guoren Deng, Rajvir Dahiya, Gurjit Kaur, Tomohiko Ohta, Manabu Furukawa, Yanping Zhang and Jennifer J. Carlisle Michel and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Journal of Virology.

In The Last Decade

Joseph McCarville

21 papers receiving 757 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph McCarville United States	11	569	179	131	124	100	22	769
Eugene Dempsey Ireland	15	318 0.6×	79 0.4×	140 1.1×	119 1.0×	111 1.1×	24	686
Nianli Liu China	16	401 0.7×	117 0.7×	108 0.8×	188 1.5×	123 1.2×	33	714
Tuhina Mazumdar United States	17	398 0.7×	232 1.3×	146 1.1×	106 0.9×	29 0.3×	32	785
Wansong Lin China	16	387 0.7×	209 1.2×	95 0.7×	233 1.9×	47 0.5×	35	653
Andrea Franconi France	5	421 0.7×	136 0.8×	129 1.0×	108 0.9×	161 1.6×	7	693
Martin R. Higgs United Kingdom	18	643 1.1×	309 1.7×	265 2.0×	89 0.7×	193 1.9×	32	968
Li‐Jung Juan Taiwan	18	1.1k 1.9×	268 1.5×	215 1.6×	182 1.5×	37 0.4×	20	1.4k
Shirine Benhenda France	9	934 1.6×	249 1.4×	329 2.5×	93 0.8×	195 1.9×	10	1.2k
Sukeshi Patel Arora United States	14	290 0.5×	452 2.5×	136 1.0×	92 0.7×	47 0.5×	59	868
Annacarmen Petrizzo Italy	18	354 0.6×	439 2.5×	118 0.9×	95 0.8×	139 1.4×	30	922

Countries citing papers authored by Joseph McCarville

Since Specialization

Citations

This map shows the geographic impact of Joseph McCarville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph McCarville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph McCarville more than expected).

Fields of papers citing papers by Joseph McCarville

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph McCarville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph McCarville. The network helps show where Joseph McCarville may publish in the future.

Co-authorship network of co-authors of Joseph McCarville

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph McCarville. A scholar is included among the top collaborators of Joseph McCarville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph McCarville. Joseph McCarville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

McCarville, Joseph, et al.. (2020). Evidence that the Human Cytomegalovirus IE2-86 Protein Binds mdm2 and Facilitates mdm2 Degradation. UNC Libraries.

2.

Han, Bin, Hadas Dvory‐Sobol, Andrew E. Greenstein, et al.. (2015). Development and application of a fast, reproducible assay to measure HCV NS3 protease activity using Escherichia coli lysate. Journal of Virological Methods. 225. 76–86. 3 indexed citations

3.

Vince, Bradley, John M. Hill, Eric Lawitz, et al.. (2014). A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4. Journal of Hepatology. 60(5). 920–927. 19 indexed citations

4.

Chapron, Christopher, Rebecca Glen, Massimiliano La Colla, et al.. (2014). Synthesis of 2′-O,4′-C-alkylene-bridged ribonucleosides and their evaluation as inhibitors of HCV NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 24(12). 2699–2702. 10 indexed citations

5.

Bilello, John P., Joseph McCarville, Massimiliano La Colla, et al.. (2014). In VitroActivity and Resistance Profile of Samatasvir, a Novel NS5A Replication Inhibitor of Hepatitis C Virus. Antimicrobial Agents and Chemotherapy. 58(8). 4431–4442. 21 indexed citations

6.

McCarville, Joseph, Maria Seifer, David N. Standring, & Douglas L. Mayers. (2013). 1209 TREATMENT-EMERGENT VARIANTS FOLLOWING 3 DAYS OF MONOTHERAPY WITH IDX719, A POTENT, PAN-GENOTYPIC NS5A INHIBITOR, IN SUBJECTS INFECTED WITH HCV GENOTYPES 1–4. Journal of Hepatology. 58. S491–S492. 4 indexed citations

7.

Lalezari, Jacob, Terry Box, William O’Riordan, et al.. (2013). Idx184 in Combination with Pegylated Interferon-α2A and Ribavirin for 2 Weeks in Treatment-Naive Patients with Chronic Hepatitis C. Antiviral Therapy. 18(6). 755–764. 9 indexed citations

8.

Bruijne, Joep de, André van Vliet, Christine J. Weegink, et al.. (2012). Rapid Decline of Viral RNA in Chronic Hepatitis C Patients Treated Once Daily with IDX320: A Novel Macrocyclic HCV Protease Inhibitor. Antiviral Therapy. 17(4). 633–642. 5 indexed citations

9.

Lalezari, Jacob, David M. Asmuth, Hugo E. Vargas, et al.. (2012). Short-Term Monotherapy with IDX184, a Liver-Targeted Nucleotide Polymerase Inhibitor, in Patients with Chronic Hepatitis C Virus Infection. Antimicrobial Agents and Chemotherapy. 56(12). 6372–6378. 11 indexed citations

10.

Dousson, Cyril B., Christopher Chapron, David N. Standring, et al.. (2011). 815 IDENIX NS5A HCV REPLICATION INHIBITORS WITH LOW PICOMOLAR, PAN-GENOTYPIC IN VITRO ANTIVIRAL ACTIVITY. Journal of Hepatology. 54. S326–S327. 7 indexed citations

11.

McCarville, Joseph, John P. Bilello, Ilaria Serra, et al.. (2010). 768 IN VITRO ANTIVIRAL ACTIVITY OF IDX320, A NOVEL AND POTENT MACROCYCLIC HCV PROTEASE INHIBITOR. Journal of Hepatology. 52. S298–S299. 1 indexed citations

12.

Zhang, Zhigang, David L. Evers, Joseph McCarville, et al.. (2006). Evidence that the Human Cytomegalovirus IE2-86 Protein Binds mdm2 and Facilitates mdm2 Degradation. Journal of Virology. 80(8). 3833–3843. 26 indexed citations

13.

Michel, Jennifer J. Carlisle, Joseph McCarville, & Yue Xiong. (2003). A Role for Saccharomyces cerevisiae Cul8 Ubiquitin Ligase in Proper Anaphase Progression. Journal of Biological Chemistry. 278(25). 22828–22837. 41 indexed citations

14.

Furukawa, Manabu, Yanping Zhang, Joseph McCarville, Tomohiko Ohta, & Yue Xiong. (2000). The CUL1 C-Terminal Sequence and ROC1 Are Required for Efficient Nuclear Accumulation, NEDD8 Modification, and Ubiquitin Ligase Activity of CUL1. Molecular and Cellular Biology. 20(21). 8185–8197. 8 indexed citations

15.

Furukawa, Manabu, Yanping Zhang, Joseph McCarville, Tomohiko Ohta, & Yue Xiong. (2000). The CUL1 C-Terminal Sequence and ROC1 Are Required for Efficient Nuclear Accumulation, NEDD8 Modification, and Ubiquitin Ligase Activity of CUL1. Molecular and Cellular Biology. 20(21). 8185–8197. 111 indexed citations

16.

McElhinny, Stephanie A. Nick, et al.. (2000). Ku Recruits the XRCC4-Ligase IV Complex to DNA Ends. Molecular and Cellular Biology. 20(9). 2996–3003. 302 indexed citations

17.

Dahiya, Rajvir, Joseph McCarville, Celeste Lee, et al.. (1997). Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer. International Journal of Cancer. 72(2). 283–288. 41 indexed citations

18.

Dahiya, Rajvir, Joseph McCarville, Celeste Lee, et al.. (1997). Chromosome 3p24‐26 and 3p22‐12 loss in human prostatic adenocarcinoma. International Journal of Cancer. 71(1). 20–25. 1 indexed citations

19.

Dahiya, Rajvir, Joseph McCarville, Celeste Lee, et al.. (1997). Chromosome 3p24-26 and 3p22-12 loss in human prostatic adenocarcinoma. International Journal of Cancer. 71(1). 20–25. 48 indexed citations

20.

Dahiya, Rajvir, et al.. (1997). High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma. International Journal of Cancer. 72(5). 762–767. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact